ANTIGENICS INC.

Company

AGENUS INC

Filed

March 28, 2001

Period of Report

December 31, 2000

Accession Number

0000950135-01-000959

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →